Staff Scientist, R&D Toxicology Quest Diagnostics Chantilly, Virginia
This presentation will cover 2024 NPS trends in clinical urine specimens at Quest Diagnostics. Two emerging NPS trends, carfentanil and fluorexetamine, will also be discussed.
This presentation is sponsored by Quest Diagnostics and is not certified for credit.